Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
filingDate |
2008-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb352b1d14977a57ef48a05141fa379 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75319cc58fe96388d3f84b8042e97bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e11e968556decec6cf00903934a155d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a56143f3f1e6c2eb1f329cd9130be4ec |
publicationDate |
2010-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2217232-A1 |
titleOfInvention |
4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465 |
abstract |
4-[4-(2-Adamantylcarbamoyl)-5-tert-butyl-pyrazol- 1 -yl]benzoic acid and pharmaceutically-acceptable salts thereof and a particular crystalline form of the Agent (Form 1); their use in the inhibition of 11 βHSD1, processes for making them and pharmaceutical compositions comprising them are also described. |
priorityDate |
2007-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |